|
“Defining the Immune Landscape of Diffuse Large B-cell Lymphoma” |
01/22/2018 - 12:00pm to 1:00pm |
|
Optimizing the Recognition, Surveillance, and Therapy of Patients with Hereditary Hematopoietic Disorders |
01/08/2018 - 12:00pm to 1:00pm |
|
“Neoadjuvant Pembrolizumab in Resectable Early Stage Gastroesophageal Adenocarcinoma” and “Overcoming Oncogene-Mediated Immune Exclusion to Improve Immunotherapy Responsiveness” |
12/18/2017 - 12:00pm to 1:00pm |
|
Innovations in Global Oncology Clinical Trials |
12/04/2017 - 12:00pm to 1:00pm |
|
“BRAF Mutation in Colorectal Cancer” and “Targeting DNA Repair Pathways in Mesothelioma” |
11/27/2017 - 12:00pm to 1:00pm |
|
“The Expanding Role of Germline Genetics in Cancer” |
11/20/2017 - 12:00pm to 1:00pm |
|
“Using the Genome to Achieve Precision Medicine” |
11/13/2017 - 12:00pm to 1:00pm |
|
“Understanding Normal and Malignant Hematopoiesis One Cell At a Time” |
11/06/2017 - 12:00pm to 1:00pm |
|
The Microbiome and Anticancer Immunosurveillance |
10/30/2017 - 12:00pm to 1:00pm |
|
“Cancer Risk Clinic & Center for Clinical Cancer Genetics Program Update |
10/23/2017 - 12:00pm to 1:00pm |
Facebook
Twitter
LinkedIn
Forward